Skip to main content
. 2018 Jul 13;10(7):233. doi: 10.3390/cancers10070233

Table 3.

Characteristics of the HL patients.

Characteristics No. of Patients
Nodular Sclerosis (NS) 100
 Male 53
 Age 33 (17–81)
 Treatment
   Combined modality 100%
Mixed Cellularity (MC) 23
 Male 15
 Age 39 (19–69)
 Treatment
   Combined modality 100%